Smoking rates in coronary patients over the decade 1997–2007. Results of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EUROASPIRE II and EUROASPIRE III surveys
cytuj
pobierz pliki
RIS BIB ENDNOTEChoose format
RIS BIB ENDNOTECzęstość palenia tytoniu wśród osób z chorobą niedokrwienną serca w latach 1997–2007. Wyniki Krakowskiego Programu Wtórnej Prewencji Choroby Niedokrwiennej Serca oraz polskich części badań EUROASPIRE II i EUROASPIRE III
Publication date: 2009
Public Health and Governance, 2009, Volume 7, Issue 2, pp. 44 - 48
Authors
Częstość palenia tytoniu wśród osób z chorobą niedokrwienną serca w latach 1997–2007. Wyniki Krakowskiego Programu Wtórnej Prewencji Choroby Niedokrwiennej Serca oraz polskich części badań EUROASPIRE II i EUROASPIRE III
Smoking rates in coronary patients over the decade 1997–2007. Results of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EUROASPIRE II and EUROASPIRE III surveys
Background: Smoking is one of the most important risk factors. Persisting smoking after an coronary event is related to significantly higher risk of the future cardiovascular complications. Studies performed in late nineties showed that a considerable percentage of patients continue with smoking after an coronary event. The aim of the present paper was to compare smoking rates in coronary patients in the post-discharge period in Krakow in 1997/1998, 1999/2000 and 2006/2007.
Methods: Consecutive patients hospitalized from July 1, 1996 to September 31, 1997 (first survey), from March 1, 1998 to March 30, 1999 (second survey), and from April 1, 2005 to July 31, 2006 (third survey) due to acute myocardial infarction, unstable angina or for myocardial revascularization procedures, below the age of < 71 years were identified and then followed up, interviewed and examined 6–18 months after discharge. Self-reported smoking and breath carbon monoxide was analysed.
Results: The number of patients who participated in the follow-up examinations were: 418 (78.0%) in the first survey, 427 (82.9%) in the second and 427 (79.1%) in the third survey. There was no significant change in smoking (self-reported) rates (16% vs 16% vs 19%; p = NS). When breath carbon monoxide was also analysed once again the difference did not reach significance (18% in 1999–2000 and 23% in 2006–2007; p = NS). Nicotine replacement therapy, bupropion or varenicline were also not used (0% vs 0.2% vs 0.5%; p = NS).
Conclusion: The smoking rate in coronary patients over the decade from 1997/1998 to 2006/2007 did not changed significantly. The pharmacotherapy for smoking is almost not used in coronary patients.
Polakowska M., Piotrowski W., Tykarski A. i wsp., Nałóg palenia tytoniu w populacji polskiej. Wyniki programu WOBASZ, „Kardiologia Polska” 2005; 63 (supl. 4): S626–631.
Tonstad S., Johnston J.A., Cardiovascular risks associated with smoking: a review for clinicians, „Eur. J. Cardiovasc. Prev. Rehabil.” 2006; 13: 507–514.
Critchley J., Capewell S., Smoking cessation for the secondary prevention of coronary heart disease, „Cochrane Database Syst. Rev.” 2004; 1: CD003041.
Graham I., Atar D., Borch-Johnsen K. et al., European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts), „Eur. J. Cardiovasc. Prev. Rehabil.” 2007; 14 (Suppl. 2): S1–S113.
Kawecka-Jaszcz K., Jankowski P., Pająk A. i wsp., Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca, część II: Wtórna prewencja choroby niedokrwiennej serca w okresie hospitalizacji, „Przegląd Lekarski” 2001;58: 956–963.
Euroaspire II Study Group, Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Euro Heart Survey Programme, „Eur. Heart. J.” 2001; 22:554–572.
Kotseva K., Wood D., Backer G.D. et al., EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, „Eur. J. Cardiovasc. Prev. Rehabil.” 2009; 16: 121–137.
Pająk A., Kawecka-Jaszcz K., Jankowski P. i wsp., Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca. Porównanie realizacji wtórnej prewencji choroby niedokrwiennej serca w okresie hospitalizacji w latach 1996/97 i 1998/99, „Przegląd Lekarski” 2003; 60: 136–141.
Jankowski P., Kawecka-Jaszcz K., Pajak A., i wsp., Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca. Realizacja wtórnej prewencji choroby niedokrwiennej serca w okresie po hospitalizacji w latach 1997/98 i 1999/2000, „Przegląd Lekarski” 2003; 60: 142–146.
Jankowski P., Kawecka-Jaszcz K., Pająk A. et al., Secondary prevention of coronary artery disease in hospital practice over the decade 1996–2006. Results of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EuroASPIRE II and EuroASPIRE III surveys, „Kardiologia Polska” 2009; 67: 970–976.
Pająk A., Jankowski P., Kawecka-Jaszcz K. et al., Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997–2007. Comparison of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EUROASPI48 Zeszyty Naukowe Ochrony Zdrowia. Zdrowie Publiczne i Zarządzanie RE II and EUROASPIRE III surveys, „Kardiologia Polska” 2009 (w druku).
Kotseva K., Wood D., De Backer G. et al., Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, „Lancet” 2009; 373: 929–940.
Kawecka-Jaszcz K., Jankowski P., Podolec P. et al., Polish forum for prevention guidelines on smoking, „Kardiologia Polska” 2008; 66: 125–126.
Zatoński W., Górecka D., Opolski G. i wsp., Konsensus dotyczący rozpoznawania i leczenia zespołu uzależnienia od tytoniu. Aktualizacja 2008, „Gazeta Lekarska” 2008; 216 (dodatek): 1–16.
A clinical practice guideline for treating tobacco use and dependence: 2008 update, A U.S. Public Health Service report, „Am. J. Prev. Med.” 2008; 35: 158–176.
Skibińska E., Musiał W., Prokop J. i wsp., Jak wdrażane są zasady prewencji wtórnej w dwa lata po rozpoznaniu choroby wieńcowej serca u mężczyzn, „Kardiologia Polska” 2002; 56: 286–289.
Rużyłło W., Ponikowski P., Wilkins A., Clinical characteristics and methods of treatment of patients with stable coronary heart disease in the primary care settings – the results of the Polish, Multicentre Angina Treatment Pattern (ATP) study, „Int. J. Clin. Pract.” 2004; 58: 1127–1133.
Pietrasik A., Starczewska M., Głowczyńska R. i wsp., Leczenie choroby wieńcowej – polska rzeczywistość w świetle wyników badania POLKARD_SPOK, „Przewodnik Lekarski” 2006; 6: 52–58.
Banasiak W., Wilkins A., Pociupany R. et al., Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study, „Kardiologia Polska” 2008; 66, 642–649.
Information: Public Health and Governance, 2009, Volume 7, Issue 2, pp. 44 - 48
Article type: Original article
Titles:
Częstość palenia tytoniu wśród osób z chorobą niedokrwienną serca w latach 1997–2007. Wyniki Krakowskiego Programu Wtórnej Prewencji Choroby Niedokrwiennej Serca oraz polskich części badań EUROASPIRE II i EUROASPIRE III
Smoking rates in coronary patients over the decade 1997–2007. Results of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EUROASPIRE II and EUROASPIRE III surveys
I Klinika Kardiologii i Elektrokardiologii Interwencyjnej oraz Nadciśnienia Tętniczego, Instytut Kardiologii, Uniwersytet Jagielloński Collegium Medicum, Kraków
Department of Epidemiology and Population Studies, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland
Collegium Medicum Jagiellonian University, Kraków, Poland
Published at: 2009
Article status: Open
Licence: CC BY
Percentage share of authors:
Article corrections:
-Publication languages:
PolishView count: 1904
Number of downloads: 1021